We are live on ! Find out more
IMVTU

Immunovant, Inc. Units
IMVTU

Delisted

IMVTU was delisted on the 5th of June, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Immunovant, Inc. Units in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $31.2M → $0 (-$31.2M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$19.4M
2
PA
Perceptive Advisors
New York
-$7.36M
3
PVI
Pura Vida Investments
New York
-$2.9M
4
SFM
Sphera Funds Management
Israel
-$1.56M
5
UBS Group
UBS Group
Switzerland
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
– -$19.4M -1,078,380 Closed
PA
2
Perceptive Advisors
New York
– -$7.36M -400,000 Closed
PVI
3
Pura Vida Investments
New York
– -$2.9M -175,010 Closed
SFM
4
Sphera Funds Management
Israel
– -$1.56M -94,500 Closed
UBS Group
5
UBS Group
Switzerland
– -$13K -772 Closed
TRCT
6
Tower Research Capital (TRC)
New York
– -$3K -156 Closed

IMVTU Hedge Fund Activity: Q2 2020 in Review

0 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Immunovant, Inc. Units (IMVTU) for Q2 2020, worth a combined $0 — down 100% from $31.2M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMVTU and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $19.4M sold.

  • 0 institutional investors held Immunovant, Inc. Units (IMVTU) as of Q2 2020, down from 6 in Q1 2020.
  • Funds reported $0 of Immunovant, Inc. Units stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Immunovant, Inc. Units positions in Q2 2020 and 6 closed out, a net change of -6 holders.
  • The largest Immunovant, Inc. Units seller in Q2 2020 was Cormorant Asset Management, an estimated $19.4M sold.

Based on aggregated 13F filings for Q2 2020.